Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Jennifer
J
Furin
Department of Biomedical Sciences, University of Stellenbosch, Faculty of Health Sciences, Tygerberg, South Africa.
Andreas H
AH
Diacon
Infectious Diseases BVBA, Janssen Pharmaceuticals, Beerse, Belgium. jenniferfurin@gmail.com.
Koen
K
Andries
D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D064687:Diarylquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology
D000995:Antitubercular Agents; D064687:Diarylquinolines; C493870:bedaquiline